Cargando…
DLC1 as Druggable Target for Specific Subsets of Gastric Cancer: An RNA-seq-Based Study
Background: Gastric cancer has been ranked the third leading cause of cancer death worldwide. Its detection at the early stage is difficult because patients mostly experience vague and non-specific symptoms in the early stages. Methods: The RNA-seq datasets of both gastric cancer and normal samples...
Autores principales: | Yang, Lianlei, Bhat, Adil Manzoor, Qazi, Sahar, Raza, Khalid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056469/ https://www.ncbi.nlm.nih.gov/pubmed/36984515 http://dx.doi.org/10.3390/medicina59030514 |
Ejemplares similares
-
COVIDium: a COVID-19 resource compendium
por: Satyam, Rohit, et al.
Publicado: (2021) -
scDLC: a deep learning framework to classify large sample single-cell RNA-seq data
por: Zhou, Yan, et al.
Publicado: (2022) -
Functional antagonism between CagA and DLC1 in gastric cancer
por: Hinsenkamp, Isabel, et al.
Publicado: (2022) -
DLC1 is the principal biologically-relevant down-regulated DLC family member in several cancers
por: Wang, Dunrui, et al.
Publicado: (2016) -
Single Cell RNA Sequencing Identifies a Unique Inflammatory Macrophage Subset as a Druggable Target for Alleviating Acute Kidney Injury
por: Yao, Weijian, et al.
Publicado: (2022)